Lars Hansen

Dr. Lars Hansen

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
LHLars Hansen
Lars Hansen
HTHasan Tawamie
Hasan Tawamie
YMYoshiko Murakami
Yoshiko Murakami
YMYuan Mang
Yuan Mang
SRShoaib Ur Rehman
Shoaib Ur Rehman
RJRami Abou Jamra
Rami Abou Jamra

22 March 2018 in Glycobiology
Verified
Journal Article
Open access
PDF file
HJHiren J Joshi
Hiren J Joshi
LHLars Hansen
Lars Hansen
YNYoshiki Narimatsu
Yoshiki Narimatsu
HFHudson H Freeze
Hudson H Freeze
BHBernard Henrissat
Bernard Henrissat
KSKatrine T Schjoldager
Katrine T Schjoldager
Glycosylation of proteins, lipids and proteoglycans in human cells involves at least 167 identified glycosyltransferases (GTfs), and these orchestrate the biosynthesis of diverse types of glycoconjugates and glycan structures. Mutations in this part of the genome—the GTf-genome—cause more than 58 rare, monogenic congenital disorders of glycosylation (CDGs). They are also statistically associated with a large number of complex phenotypes, diseases or predispositions to complex diseases based on Genome-Wide Association Studies (GWAS). CDGs are extremely rare and often with severe medical consequences. In contrast, GWAS are likely to identify more common genetic variations and generally involve less severe and distinct traits. We recently confirmed that structural defects in GTf genes are extremely rare, which seemed at odds with the large number of GWAS pointing to GTf-genes. To resolve this issue, we surveyed the GTf-genome for reported CDGs and GWAS candidates; we found little overlap between the two groups of genes. Moreover, GTf-genes implicated by CDG or GWAS appear to constitute different classes with respect to their: (i) predicted roles in glycosylation pathways; (ii) potential for partial redundancy by closely homologous genes; and (iii) transcriptional regulation as evaluated by RNAseq data. Our analysis suggest that more complex traits are caused by dysregulation rather than structural deficiency of GTfs, which suggests that some glycosylation reactions may be predicted to be under tight regulation for fine-tuning of important biological functions.

6 July 2012 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
Muhammad Sajid HussainMuhammad Sajid Hussain
Muhammad Sajid Hussain
SBS Marriam Bakhtiar
S Marriam Bakhtiar
MFM Farooq
M Farooq
IAI Anjum
I Anjum
EJE Janzen
E Janzen
LHLars Hansen
Lars Hansen

28 September 2014 in Glycobiology
Verified
Journal Article
Open access
PDF file
LHLars Hansen
Lars Hansen
ALAllan Lind-Thomsen
Allan Lind-Thomsen
HJHiren J Joshi
Hiren J Joshi
NPNis Borbye Pedersen
Nis Borbye Pedersen
CHChristian Theil Have
Christian Theil Have
EBEric P Bennett
Eric P Bennett
Glycosylation of proteins and lipids involves over 200 known glycosyltransferases (GTs), and deleterious defects in many of the genes encoding these enzymes cause disorders collectively classified as congenital disorders of glycosylation (CDGs). Most known CDGs are caused by defects in glycogenes that affect glycosylation globally. Many GTs are members of homologous isoenzyme families and deficiencies in individual isoenzymes may not affect glycosylation globally. In line with this, there appears to be an underrepresentation of disease-causing glycogenes among these larger isoenzyme homologous families. However, genome-wide association studies have identified such isoenzyme genes as candidates for different diseases, but validation is not straightforward without biomarkers. Large-scale whole-exome sequencing (WES) provides access to mutations in, for example, GT genes in populations, which can be used to predict and/or analyze functional deleterious mutations. Here, we constructed a draft of a functional mutational map of glycogenes, GlyMAP, from WES of a rather homogenous population of 2000 Danes. We cataloged all missense mutations and used prediction algorithms, manual inspection and in case of carbohydrate-active enzymes family GT27 experimental analysis of mutations to map deleterious mutations. GlyMAP (http://glymap.glycomics.ku.dk) provides a first global view of the genetic stability of the glycogenome and should serve as a tool for discovery of novel CDGs.

10 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Kentaro KatoKentaro Kato
Kentaro Kato
LHLars Hansen
Lars Hansen
HCHenrik Clausen
Henrik Clausen
Mucin-type O-glycosylation involves the attachment of glycans to an initial O-linked N-acetylgalactosamine (GalNAc) on serine and threonine residues on proteins. This process in mammals is initiated and regulated by a large family of 20 UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) (EC 2.4.1.41). The enzymes are encoded by a large gene family (GALNTs). Two of these genes, GALNT2 and GALNT3, are known as monogenic autosomal recessive inherited disease genes with well characterized phenotypes, whereas a broad spectrum of phenotypes is associated with the remaining 18 genes. Until recently, the overlapping functionality of the 20 members of the enzyme family has hindered characterizing the specific biological roles of individual enzymes. However, recent evidence suggests that these enzymes do not have full functional redundancy and may serve specific purposes that are found in the different phenotypes described. Here, we summarize the current knowledge of GALNT and associated phenotypes.

19 February 2014 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
LHLars Hansen
Lars Hansen
SCSophie Comyn
Sophie Comyn
YMYuan Mang
Yuan Mang
ALAllan Lind-Thomsen
Allan Lind-Thomsen
LMLayne Myhre
Layne Myhre
DPDave Pilgrim
Dave Pilgrim
Genome-wide linkage analysis, followed by targeted deep sequencing, in a Danish multigeneration family with juvenile cataract revealed a region of chromosome 17 co-segregating with the disease trait. Affected individuals were heterozygous for two potentially protein-disrupting alleles in this region, in ACACA and UNC45B. As alterations of the UNC45B protein have been shown to affect eye development in model organisms, effort was focused on the heterozygous UNC45B missense mutation. UNC45B encodes a myosin-specific chaperone that, together with the general heat shock protein HSP90, is involved in myosin assembly. The mutation changes p.Arg805 to Trp in the UCS domain, an amino acid that is highly conserved from yeast to human. UNC45B is strongly expressed in the heart and skeletal muscle tissue, but here we show expression in human embryo eye and zebrafish lens. The zebrafish mutant steif, carrying an unc45b nonsense mutation, has smaller eyes than wild-type embryos and shows accumulation of nuclei in the lens. Injection of RNA encoding the human wild-type UNC45B protein into the steif homozygous embryo reduced the nuclei accumulation and injection of human mutant UNC45B cDNA in wild-type embryos resulted in development of a phenotype similar to the steif mutant. The p.Arg805Trp alteration in the mammalian UNC45B gene suggests that developmental cataract may be caused by a defect in non-muscle myosin assembly during maturation of the lens fiber cells.